NCT02191878 2019-01-16
Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
Arbutus Biopharma Corporation
Phase 1/2 Completed
Arbutus Biopharma Corporation
National Institutes of Health Clinical Center (CC)